Logo image of MRAI

MARPAI INC-CLASS A (MRAI) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:MRAI - US5713542083 - Common Stock

0.9 USD
-1.04 (-53.61%)
Last: 5/28/2024, 8:00:01 PM
0.9004 USD
+0 (+0.04%)
After Hours: 5/28/2024, 8:00:01 PM
Fundamental Rating

2

Taking everything into account, MRAI scores 2 out of 10 in our fundamental rating. MRAI was compared to 148 industry peers in the Insurance industry. Both the profitability and financial health of MRAI have multiple concerns. MRAI is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year MRAI has reported negative net income.
In the past year MRAI has reported a negative cash flow from operations.
In the past 5 years MRAI always reported negative net income.
In the past 5 years MRAI always reported negative operating cash flow.
MRAI Yearly Net Income VS EBIT VS OCF VS FCFMRAI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 -10M -20M -30M

1.2 Ratios

The Return On Assets of MRAI (-80.54%) is worse than 97.81% of its industry peers.
Industry RankSector Rank
ROA -80.54%
ROE N/A
ROIC N/A
ROA(3y)-59.97%
ROA(5y)-55.71%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
MRAI Yearly ROA, ROE, ROICMRAI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 0 200 -200 -400

1.3 Margins

MRAI has a better Gross Margin (34.90%) than 91.97% of its industry peers.
MRAI does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 34.9%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
MRAI Yearly Profit, Operating, Gross MarginsMRAI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 0 -50 -100

More info and screens

1

2. Health

2.1 Basic Checks

MRAI does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for MRAI has been increased compared to 1 year ago.
The debt/assets ratio for MRAI is higher compared to a year ago.
MRAI Yearly Shares OutstandingMRAI Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2M 4M 6M
MRAI Yearly Total Debt VS Total AssetsMRAI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 10M 20M 30M 40M

2.2 Solvency

Based on the Altman-Z score of -5.04, we must say that MRAI is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of MRAI (-5.04) is better than 65.69% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -5.04
ROIC/WACCN/A
WACC6.4%
MRAI Yearly LT Debt VS Equity VS FCFMRAI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 0 20M -20M

2.3 Liquidity

MRAI has a Current Ratio of 0.82. This is a bad value and indicates that MRAI is not financially healthy enough and could expect problems in meeting its short term obligations.
MRAI's Current ratio of 0.82 is fine compared to the rest of the industry. MRAI outperforms 78.10% of its industry peers.
A Quick Ratio of 0.82 indicates that MRAI may have some problems paying its short term obligations.
MRAI has a Quick ratio of 0.82. This is in the better half of the industry: MRAI outperforms 78.10% of its industry peers.
Industry RankSector Rank
Current Ratio 0.82
Quick Ratio 0.82
MRAI Yearly Current Assets VS Current LiabilitesMRAI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 5M 10M 15M 20M 25M

More info and screens

5

3. Growth

3.1 Past

MRAI shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 45.44%, which is quite impressive.
The Revenue has grown by 25.44% in the past year. This is a very strong growth!
EPS 1Y (TTM)45.44%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%70.51%
Revenue 1Y (TTM)25.44%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-23.65%

3.2 Future

The Earnings Per Share is expected to grow by 38.31% on average over the next years. This is a very strong growth
MRAI is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 38.93% yearly.
EPS Next Y66.51%
EPS Next 2Y38.31%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-2.59%
Revenue Next 2Y38.93%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

MRAI Yearly Revenue VS EstimatesMRAI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2025 20M 40M 60M
MRAI Yearly EPS VS EstimatesMRAI Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 -1 -2 -3 -4 -5

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

MRAI reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for MRAI. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
MRAI Price Earnings VS Forward Price EarningsMRAI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60 80

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
MRAI Per share dataMRAI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2

4.3 Compensation for Growth

A more expensive valuation may be justified as MRAI's earnings are expected to grow with 38.31% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y38.31%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for MRAI!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

MARPAI INC-CLASS A

NASDAQ:MRAI (5/28/2024, 8:00:01 PM)

After market: 0.9004 +0 (+0.04%)

0.9

-1.04 (-53.61%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupInsurance
GICS IndustryInsurance
Earnings (Last)05-09 2024-05-09/amc
Earnings (Next)08-01 2024-08-01/amc
Inst OwnersN/A
Inst Owner Change0%
Ins Owners42.01%
Ins Owner Change17.27%
Market Cap9.28M
Revenue(TTM)34.87M
Net Income(TTM)-24.23M
Analysts82.86
Price Target6.12 (580%)
Short Float %0.19%
Short Ratio0.03
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-9.41%
Min Revenue beat(2)-16.78%
Max Revenue beat(2)-2.05%
Revenue beat(4)2
Avg Revenue beat(4)0.29%
Min Revenue beat(4)-16.78%
Max Revenue beat(4)19.46%
Revenue beat(8)5
Avg Revenue beat(8)0.66%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-50%
EPS NQ rev (1m)-13.33%
EPS NQ rev (3m)-155%
EPS NY rev (1m)0.68%
EPS NY rev (3m)-356.25%
Revenue NQ rev (1m)-14.29%
Revenue NQ rev (3m)-67.72%
Revenue NY rev (1m)-12.49%
Revenue NY rev (3m)-61.59%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.27
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-3.16
EYN/A
EPS(NY)-0.39
Fwd EYN/A
FCF(TTM)-1.24
FCFYN/A
OCF(TTM)-1.24
OCFYN/A
SpS3.38
BVpS-1.41
TBVpS-2.32
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -80.54%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 34.9%
FCFM N/A
ROA(3y)-59.97%
ROA(5y)-55.71%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover1.16
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.82
Quick Ratio 0.82
Altman-Z -5.04
F-Score3
WACC6.4%
ROIC/WACCN/A
Cap/Depr(3y)38.73%
Cap/Depr(5y)574.66%
Cap/Sales(3y)5.4%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)45.44%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%70.51%
EPS Next Y66.51%
EPS Next 2Y38.31%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)25.44%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-23.65%
Revenue Next Year-2.59%
Revenue Next 2Y38.93%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y26.11%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year75.31%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y56.51%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y55.31%
OCF growth 3YN/A
OCF growth 5YN/A

MARPAI INC-CLASS A / MRAI FAQ

Can you provide the ChartMill fundamental rating for MARPAI INC-CLASS A?

ChartMill assigns a fundamental rating of 2 / 10 to MRAI.


Can you provide the valuation status for MARPAI INC-CLASS A?

ChartMill assigns a valuation rating of 1 / 10 to MARPAI INC-CLASS A (MRAI). This can be considered as Overvalued.


How profitable is MARPAI INC-CLASS A (MRAI) stock?

MARPAI INC-CLASS A (MRAI) has a profitability rating of 1 / 10.